Exceptional Investor Tax Benefits for Medtech Companies

15 10 2013

How do you attract capital to your medtech company when the longer exit scares away investors? HA&W Partner Mitchell Kopelman and Senior Manager Ori Epstein recently wrote an article on an often overlooked tax code section that may help you reel in those investors. Check it out on MD+DI.

Habif, Arogeti & Wynne, LLP